Computerized cognitive training in prostate cancer patients on androgen deprivation therapy: a pilot study
- 350 Downloads
Prostate cancer patients who have undergone androgen deprivation therapy (ADT) may experience cognitive impairment, yet there is an unmet need for nonpharmacological interventions to address cognitive impairment in this population. This study examines the feasibility, acceptability, and preliminary efficacy of a home-based computerized cognitive training (CCT) program to treat cancer-related cognitive impairment.
Sixty men who had received ≥ 3 months of ADT were screened for at least mild cognitive or neurobehavioral impairment and randomized to 8 weeks of CCT or usual care. Follow-up assessments occurred immediately post-intervention or equivalent (T2) and 8 weeks later (T3). The acceptability of CCT was also assessed.
Feasibility:A priori feasibility thresholds were partially met (i.e., randomization rate > 50%, retention rate > 70% excluding CCT drop-outs, but < 70% for intent-to-treat). Acceptability: Participants were mostly satisfied with CCT and found it somewhat enjoyable, though barriers to uptake existed. Preliminary efficacy: Linear mixed models indicated significant time by group effects favorable to CCT in reaction time (p = .01), but unfavorable to CCT in verbal and visual memory (ps < .05). Memory was temporarily suppressed in the CCT group at T2, but normalized by T3. There was no effect of CCT on self-reported cognitive functioning, neurobehavioral functioning, nor quality of life.
This study provides tentative support for the feasibility and acceptability of CCT to treat mild cognitive impairment in ADT patients. CCT had a beneficial effect on reaction time, but temporarily suppressed memory. CCT’s benefits may be limited to a narrow area of functioning. Larger-scale studies are needed.
KeywordsOncology Hormone therapy Cancer-related cognitive impairment Cognition Computers Antiandrogens
We thank Posit Science and CNS Vital Signs for providing their programs to this study at no cost.
This work was supported by the American Cancer Society (L.W., grant no. PF-12-041-01-CPPB) and the National Cancer Institute of the National Institutes of Health (L.W., grant no. 5K07CA184145-03).
Compliance with ethical standards
Informed consent was obtained from all participants.
Conflicts of interest
Wu and Amidi report personal fees from Bayer Pharmaceutical outside the submitted work. The other authors have no conflicts of interest to declare. Wu has full control of all primary data and agrees to allow the journal to review this data if requested.
Content is solely the responsibility of the authors and does not necessarily represent the official view of the National Institutes of Health.
- 1.Han M, Partin AW, Pound CR, Epstein JI, Walsh PC (2001) Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 28(3):555–565. https://doi.org/10.1016/S0094-0143(05)70163-4 CrossRefPubMedGoogle Scholar
- 2.Singh J, Trabulsi EJ, Gomella LG (2010) Is there an optimal management for localized prostate cancer? Clin Interv Aging 5:187–197. https://doi.org/10.2147/CIA.56555
- 3.Gonzalez BD, Jim HS, Booth-Jones M, Small BJ, Sutton SK, Lin HY, Park JY, Spiess PE, Fishman MN, Jacobsen PB (2015) Course and predictors of cognitive function in patients with prostate cancer receiving androgen-deprivation therapy: a controlled comparison. J Clin Oncol 33(18):2021–2027. https://doi.org/10.1200/JCO.2014.60.1963 CrossRefPubMedPubMedCentralGoogle Scholar
- 4.McGinty HL, Phillips KM, Jim HS, Cessna JM, Asvat Y, Cases MG, Small BJ, Jacobsen PB (2014) Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis. Support Care Cancer 22(8):2271–2280. https://doi.org/10.1007/s00520-014-2285-1 CrossRefPubMedPubMedCentralGoogle Scholar
- 6.Wu LM, Tanenbaum ML, Dijkers MPJM, Amidi A, Hall SJ, Penedo FJ, Diefenbach MA (2016) Cognitive and neurobehavioral symptoms in patients with non-metastatic prostate cancer treated with androgen deprivation therapy or observation: a mixed methods study. Soc Sci Med 156:80–89. https://doi.org/10.1016/j.socscimed.2016.03.016 CrossRefGoogle Scholar
- 7.Galvão DA, Taaffe DR, Spry N, Joseph D, Newton RU (2010) Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol 28(2):340–347. https://doi.org/10.1200/JCO.2009.23.2488 CrossRefPubMedGoogle Scholar
- 8.Treanor CJ, McMenamin UC, O’Neill RF, Cardwell CR, Clarke MJ, Cantwell M, Donnelly M (2016) Non-pharmacological interventions for cognitive impairment due to systemic cancer treatment. Cochrane Database Syst Rev 2016:CD011325. https://doi.org/10.1002/14651858.CD011325.pub2
- 9.Bray VJ, Dhillon HM, Bell ML, Kabourakis M, Fiero MH, Yip D, Boyle F, Price MA, Vardy JL (2017) Evaluation of a web-based cognitive rehabilitation program in cancer survivors reporting cognitive symptoms after chemotherapy. J Clin Oncol 35(2):217–225. https://doi.org/10.1200/JCO.2016.67.8201 CrossRefPubMedGoogle Scholar
- 13.Kesler S, Hadi Hosseini SM, Heckler C, Janelsins M, Palesh O, Mustian K, Morrow G (2013) Cognitive training for improving executive function in chemotherapy-treated breast cancer survivors. Clin Breast Cancer 13(4):299–306. https://doi.org/10.1016/j.clbc.2013.02.004 CrossRefPubMedPubMedCentralGoogle Scholar
- 19.Richardson-Vejlgaard R, Dawes S, Heaton RK, Bell MD (2009) Validity of cognitive complaints in substance-abusing patients and non-clinical controls: the Patient’s Assessment of Own Functioning Inventory (PAOFI). Psychiatry Res 169(1):70–74. https://doi.org/10.1016/j.psychres.2008.06.018 CrossRefPubMedPubMedCentralGoogle Scholar
- 21.Grace J, Malloy PF (2001) Frontal Systems Behavior Scale (FrSBe): professional manual. Psychological Assessment Resources, LutzGoogle Scholar
- 24.Smith GE, Housen P, Yaffe K, Ruff R, Kennison RF, Mahncke HW, Zelinski EM (2009) A cognitive training program based on principles of brain plasticity: results from the Improvement in Memory with Plasticity-based Adaptive Cognitive Training (IMPACT) study. J Am Geriatr Soc 57(4):594–603. https://doi.org/10.1111/j.1532-5415.2008.02167.x CrossRefPubMedPubMedCentralGoogle Scholar
- 25.Ball K, Berch DB, Helmers KF, Jobe JB, Leveck MD, Marsiske M, Morris JN, Rebok GW, Smith DM, Tennstedt SL, Unverzagt FW, Willis SL, ACTIVE Study Group (2002) Effects of cognitive training interventions with older adults: a randomized controlled trial. JAMA 288(18):2271–2281. https://doi.org/10.1001/jama.288.18.2271 CrossRefPubMedPubMedCentralGoogle Scholar
- 26.Rebok GW, Ball K, Guey LT, Jones RN, Kim HY, King JW, Marsiske M, Morris JN, Tennstedt SL, Unverzagt FW, Willis SL, ACTIVE Study Group (2014) Ten-year effects of the advanced cognitive training for independent and vital elderly cognitive training trial on cognition and everyday functioning in older adults. J Am Geriatr Soc 62(1):16–24. https://doi.org/10.1111/jgs.12607 CrossRefGoogle Scholar
- 27.Wolinsky FD, Vander Weg MW, Howren MB, Jones MP, Dotson MM (2013) A randomized controlled trial of cognitive training using a visual speed of processing intervention in middle aged and older adults. PLoS One 8(5):e61624. https://doi.org/10.1371/journal.pone.0061624 CrossRefPubMedPubMedCentralGoogle Scholar
- 33.Cohen J (1988) Statistical power analysis for the behavioural sciences, 2nd edn. Lawrence Erlbaum Associates, New YorkGoogle Scholar
- 34.Mahncke HW, Connor BB, Appelman J, Ahsanuddin ON, Hardy JL, Wood RA, Joyce NM, Boniske T, Atkins SM, Merzenich MM (2006) Memory enhancement in healthy older adults using a brain plasticity-based training program: a randomized, controlled study. Proc Natl Acad Sci U S A 103(33):12523–12528. https://doi.org/10.1073/pnas.0605194103 CrossRefPubMedPubMedCentralGoogle Scholar
- 38.Yanez B, McGinty HL, Mohr DC, Begale MJ, Dahn JR, Flury SC, Perry KT, Penedo FJ (2015) Feasibility, acceptability, and preliminary efficacy of a technology-assisted psychosocial intervention for racially diverse men with advanced prostate cancer. Cancer 121(24):4407–4415. https://doi.org/10.1002/cncr.29658 CrossRefPubMedPubMedCentralGoogle Scholar